基本信息
浏览量:67
职业迁徙
个人简介
Dr. Morgentaler is credited with shattering the decades-old belief that testosterone therapy is risky for prostate cancer, and pioneering the modern use of testosterone in men. More recently, Dr. Morgentaler has been a leading scientific figure in the global discussion regarding cardiovascular risks of testosterone therapy. Dr. Morgentaler has published over 130 scientific articles, including leading medical journals such as The New England Journal of Medicine, The Lancet, The Journal of the American Medical Association, and Cancer.
研究兴趣
论文共 323 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Abraham Morgentaler, Han M. Hanafy
SEXUAL MEDICINE REVIEWS (2023)
Journal of Future Robot Lifeno. 1 (2022): 3-16
Androgens: Clinical Research and Therapeuticsno. 1 (2022): 233-241
引用0浏览0引用
0
0
Androgens: Clinical Research and Therapeuticsno. 1 (2022): 54-55
Androgens: Clinical Research and Therapeuticsno. 1 (2022): 31-40
Androgens: clinical research and therapeuticsno. 1 (2022): 41-53
Androgens: Clinical Research and Therapeuticsno. 1 (2022): 78-79
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn